Poland· PL-100124236

Tanatril

A imidapril product containing imidaprili hydrochloridum, registered in Poland by Bausch Health Ireland Ltd.. The same ATC class is registered in 6 of our 19 countries.

ATC C09AA16

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTanatrilATCC09AA16REGISTER NO.PL-100124236PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Imidapril is registered in 6 of 19 countries.

Countries holding a registration under ATC C09AA16 (imidapril), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose

Imidapril · ATC C09AA16

6 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Japan
  • Polandprice
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of imidapril costs, country by country.

Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Imidapril · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • ES Spain$0.24
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Imidaprili hydrochloridum
Manufacturer
Bausch Health Ireland Ltd.
Country
Poland (PL)
ATC code
C09AA16
ATC class
Imidapril
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991070014

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

21 interactions on record for imidapril.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Imidapril · interactions on record

21 records

21 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Imidapril in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All imidapril products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Austria · Tanatril
  • Czechia · Tanatril
  • Spain · Hipertene, Imidapril Dari Pharma
  • United Kingdom (Northern Ireland) · Imidapril Northumbria Pharma, Imidapril Northumbria Pharma Ltd
  • Portugal · Cardipril

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2b223031-852c-4bdf-bd19-f4aa04919dad
GET /v1/drugs/2b223031-852c-4bdf-bd19-f4aa04919dad?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "20 mg",
  "packaging": "05909991070014 ¦ Rp ¦ 23413\n28 tabl.",
  "substance": "Imidaprili hydrochloridum 20 mg",
  "common_name": "Imidaprili hydrochloridum",
  "pl_product_id": "100124236",
  "pozwolenie_nr": "10700",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about imidapril.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.